191
|
|
|
MYC associated zinc finger protein |
PUR1, Pur-1, SAF-1, SAF-2, SAF-3, ZF87, ZNF801, Zif87 |
|
192
|
|
|
Mab-21 domain containing 2 |
C3orf59, D2A, hMB21D2 |
|
193
|
|
|
Methyl-CpG binding domain protein 1 |
CXXC3, PCM1, RFT |
|
194
|
|
|
Methyl-CpG binding domain protein 2 |
DMTase, NY-CO-41 |
Benign prostatic hyperplasia, Bipolar disorder, Corneal edema, Hoarding disorder, Inflammatory bowel disease, Lung cancer, Neurotic disorder, Oligodendroglioma, Periodontitis, Prostate cancer, Prostatic neoplasms, Psoriasis, Psoriasis vulgaris, Schizophrenia |
195
|
|
|
Methyl-CpG binding domain protein 3 |
- |
|
196
|
|
|
Methyl-CpG binding domain protein 3 like 2 |
- |
|
197
|
|
|
Methyl-CpG binding domain 4, DNA glycosylase |
MED1, TPDS2, UVM1 |
|
198
|
|
|
Methyl-CpG binding domain protein 5 |
C2DELq23.1, DEL2Q23.1, MRD1 |
Atrial fibrillation, Autism, Nonsyndromic intellectual disability, Bipolar disorder, Neurodevelopmental disorder, Developmental and epileptic encephalopathy, Global developmental delay, Gout, Intellectual developmental disorder, Major depressive disorder, Myocardial infarction, Neurotic disorder, Non-specific syndromic intellectual disability, Peripheral arterial disease, Schizophrenia |
199
|
|
|
Methyl-CpG binding domain protein 6 |
- |
|
200
|
|
|
MAP3K12 binding inhibitory protein 1 |
- |
|